InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,615.67
(
0.36%
)
US TECH 100
18,903.60
(
-0.13%
)
Dow Jones
41,286.31
(
0.46%
)
Brent Oil
72.42
(
0.62%
)
Bitcoin
58,101.70
(
-0.06%
)
Post# of 58465
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Renee

Send PM Follow Ignore
Followers 1514
Posts 35459
Boards Moderated 7
Alias Born 07/12/2004

Renee

Member Level

Re: Renee post# 17228

Tuesday, 04/07/2009 9:00:54 AM

Tuesday, April 07, 2009 9:00:54 AM

Post# of 58465
45 % responders survived with Genasense compared to 24 % who survived with chemotherapy alone .

That's nearly DOUBLE the survival rate with Genasense .

Shouldn't be rocket science to deduct that Genasense will be worth a fortune , predicated on FDA approval ....and EMEA approval for Europe .

Renee

To bite the worm of incite is to bite the HOOK of the antagonist . They win .

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up